1. Spinal Muscular Atrophy Mortality Despite Novel Medications: Case Reports.
- Author
-
Bach, John R., Conceição, Nayara, and Goncalves, Miguel R.
- Subjects
- *
TREATMENT of spinal muscular atrophy , *TRACHEOTOMY , *CRYING , *CONTINUOUS positive airway pressure , *GENE therapy , *INFANT mortality , *VITAL capacity (Respiration) , *OXIMETRY , *OXYGEN therapy , *HOSPITAL emergency services , *MEDICAL suction , *INTUBATION , *INSUFFLATION , *ARTIFICIAL respiration , *NASOPHARYNX , *EXTUBATION , *SPINAL muscular atrophy , *MEDICAL care costs - Abstract
Despite neweffective medications, patients with spinal muscular atrophy types 1-3 can continue to have inadequate cough flows to prevent episodes of acute respiratory failure. Ventilator unweanable intubated patients are thought to require tracheostomy tubes. As a result, potentially beneficial medications may be discontinued and patients die despite receiving these medications. Three cases are presented of medically treated, physically strengthening children, with spinal muscular atrophy type 1. All three subsequently died or underwent tracheotomy. However, there is no evidence of extubation attempts to noninvasive ventilatory support settings or optimal mechanical insufflation-exsufflation despite this option being described to be over 98% successful for extubating unweanable medically untreated children with spinal muscular atrophy 1. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF